| ABSTRACT
Objective: The purpose of the present study was firstly to identify the effectiveness of EudragitVR polymers
(EudragitVR RL, RS, L100-55, L100, S100 and E100) in inhibition of celecoxib precipitation from buffer
solutions (pH ¼ 6.8). Furthermore, the influence of EudragitVR polymers on non-sink dissolution behavior
of celecoxib from solid dispersions was investigated.
Methods: Solid dispersions were prepared by the rotary evaporation method. In vitro dissolution studies,
FT-IR and differential scanning calorimetry were employed to characterize the formulations.
Results: The results revealed that EudragitVR E100, L100 and S100 inhibited precipitation of celecoxib efficiently.
It is understood that crystallization during the dissolution of solid dispersions could happen
through crystallization from solid matrix following contact with the dissolution medium or from the
supersaturated solution produced following dissolution. The supersaturated drug concentrations attained
from the dissolution of EudragitVR -celecoxib solid dispersions were almost similar, suggesting that crystallization
from solid matrix did not occur readily. However, only solid dispersions containing efficient crystallization
inhibitor polymers were able to maintain the supersaturated solution up to the end of the
dissolution run.
Conclusion: Results revealed that the principal mechanism of attaining supersaturated solution of celecoxib
from solid dispersions was related to crystallization inhibition from solution not from solid matrix. |